We aimed to perform a standardized review of available mobile health (mHealth) applications (apps) for systemic lupus erythematosus (SLE) and to conduct a systematic review of the literature on mHealth technologies in SLE.
Methods
Google Play and AppStore in the United States of America were queried and the quality of eligible mHealth apps was assessed using the Mobile App Rating Scale (MARS). Web of Science, EMBASE, Medline, and Cochrane databases were systematically searched from inception through June 2019.
Results
Of 324 mHealth apps found, 20 were eligible for inclusion; 10 focused on education, 7 offered tools to track patient-reported symptoms, 5 included interactive online communities, and 1 enabled emoji sharing. The reviewed apps scored poorly on the MARS quality scale with a mean score 2.3 (0.6) out of 5. Of 1147 studies identified in the literature review, 21 were eligible for inclusion; 11 studies (52.4%) focused on the development and use of mHealth for providing patient information, while only 2 (9.5%) were randomized trials of mHealth interventions.
Conclusions
Although there is growing interest in the development of mHealth technologies to support SLE patients, currently available tools are of poor quality and limited functionality, and the literature examining this area is sparse.
GordonCAmissah-ArthurM-BGayedM, et al.The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology2018; 57: 1502–1503.
5.
MehatPAtiquzzamanMEsdaileJMAviÑa-ZubietaADe VeraMA. Medication nonadherence in systemic lupus erythematosus: A systematic review. Arthritis Care Res2017; 69: 1706–1713.
6.
WilliamsEMHyerJMViswanathanR, et al.Peer-to-peer mentoring for African American women with lupus: A feasibility pilot. Arthritis Care Res (Hoboken)2018; 70: 908–917.
7.
FanouriakisAKostopoulouMAlunnoA, et al.2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis2019; 78: 736–745.
8.
WallaceDJ. Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox. Lupus2008; 17: 91–92.
9.
RyuS. mHealth: New horizons for health through mobile technologies: Based on the findings of the second global survey on eHealth. Healthc Inform Res18: 231–231.
10.
TaniCTriesteLLorenzoniVCannizzoSTurchettiGMoscaM. Health information technologies in systemic lupus erythematosus: Focus on patient assessment. Clin Exp Rheumatol2016; 34: 54–56.
11.
NussbaumRKellyCQuinbyEMacAParmantoBDiciannoBE. Systematic review of mobile health applications in rehabilitation. Arch Phys Med Rehabil2019; 100: 115–127.
RobbinsRKrebsPJagannathanRJean-LouisGDuncanDT. Health app use among US mobile phone users: Analysis of trends by chronic disease status. JMIR mHealth uHealth2017; 5: e197–e197.
14.
CvrkelT. The ethics of mHealth: Moving forward. J Dent2018; 74: S15–S20.
15.
LevineABBattermanABykerkVP, et al.Patient preferences for the development of a mobile health (mHealth) application (app) for systemic lupus erythematosus (SLE) patients: A qualitative study. Arthritis Rheumatol Conf Am Coll Rheumatol Rheumatol Heal Prof Annu Sci Meet ACR/ARHP2015; 67: 5–7.
16.
MoherDShamseerLClarkeM, et al.Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev2015; 4: 1–1.
17.
Higgins JPT GS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org (Accessed 1 May 2019). Cochrane Collab.
18.
StatCounter 1999-2019., All rights reserved. Mobile Operating System Market Share Worldwide.
19.
StoyanovSRHidesLKavanaghDJZelenkoOTjondronegoroDManiM. Mobile App Rating Scale: A new tool for assessing the quality of health mobile apps. JMIR mHealth uHealth2015; 3: e27–e27.
20.
MachadoGCPinheiroMBLeeH, et al.Smartphone apps for the self-management of low back pain: A systematic review. Best Pract Res Clin Rheumatol2016; 30: 1098–1109.
21.
Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from URL http//www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Accessed 1 May 2019).
22.
WilliamsEMLorigKGloverS, et al.Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN): Study protocol for a randomized controlled trial of a unique a la carte intervention approach to self-management of lupus in African Americans. BMC Health Serv Res2016; 16: 339–339.
23.
Balderas-DíazSMartínezMPGuerrero-ContrerasG, et al.Using actigraphy and mHealth Systems for an objective analysis of sleep quality on systemic lupus erythematosus patients. Methods Inf Med2017; 56: 171–179.
24.
RichterJGBeckerAKochT, et al.Self-assessments of patients via Tablet PC in routine patient care: Comparison with standardised paper questionnaires. Ann Rheum Dis2008; 67: 1739–1741.
25.
ReynoldsMHoiABuchananRRC. Assessing the quality, reliability and readability of online health information regarding systemic lupus erythematosus. Lupus2018; 27: 1911–1917.
26.
MeunierBJourde-ChicheNManciniJChekrounMRetornazFChicheL. Characteristics and information searched for by French patients with systemic lupus erythematosus: A web-community data-driven online survey. Lupus2016; 25: 370–375.
27.
Callejas-RubioJLRíos-FernándezRBarnosi-MarínAC, et al.Health-related Internet use by lupus patients in southern Spain. Clin Rheumatol2014; 33: 567–573.
28.
RichterJGBeckerAKochT, et al.Internet use in rheumatology outpatients in 2006: Gender less important. Clin Exp Rheumatol2009; 27: 15–21.
29.
SciasciaSRadinM. What can Google and Wikipedia can tell us about a disease? Big Data trends analysis in systemic lupus erythematosus. Int J Med Inform2017; 107: 65–69.
30.
NevilleCDa CostaDMillC, et al.The needs of persons with lupus and health care providers: A qualitative study aimed toward the development of the Lupus Interactive Navigator™. Lupus2014; 23: 176–182.
31.
Herschman J, Kasenberg T, Levy D, et al. Development of a smartphone app for adolescents with lupus: A collaborative meeting-based methodology inclusive of a wide range of stakeholders. Rev Panam Salud Publica May–Jun: 35.
32.
YoungSPHendersonECheseldineDL, et al.Development and assessment of a World Wide Web site for systemic lupus erythematosus patient information. Lupus2002; 11: 478–484.
33.
LiLCFeehanLMShawC, et al.A technology-enabled counselling program versus a delayed treatment control to support physical activity participation in people with inflammatory arthritis: Study protocol for the OPAM-IA randomized controlled trial. BMC Rheumatol2017; 1: 6–6.
34.
MendelsonC. Gentle hugs: Internet listservs as sources of support for women with lupus. ANS Adv Nurs Sci2003; 26: 299–306.
35.
van MierloTFournierRInghamM. Targeting medication non-adherence behavior in selected autoimmune diseases: A systematic approach to digital health program development. PLoS One2015; 10: e0129364–e0129364.
36.
Sarabi RE, Sadoughi F, Orak RJ. The effectiveness of mobile phone text messaging in improving medication adherence for patients with chronic diseases: A systematic review. 18. Epub ahead of print 2016. DOI: 10.5812/ircmj.25183.Review.
37.
RimmerJHWangEPellegriniCALulloCGerberBS. Telehealth weight management intervention for adults with physical disabilities. Am J Phys Med Rehabil2013; 92: 1084–1094.
38.
TingTVKudalkarDNelsonS, et al.Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus. J Rheumatol2012; 39: 174–179.
39.
RheeRLVon FeldtJMSchumacherHRMerkelPA. Readability and suitability assessment of patient education materials in rheumatic diseases. Arthritis Care Res (Hoboken)2013; 65: 1702–1706.
40.
JamillouxYSarabiMKéreverS, et al.Adherence to online monitoring of patient-reported outcomes by patients with chronic inflammatory diseases: A feasibility study. Lupus2015; 24: 1429–1436.
41.
ScalziLVHollenbeakCSMascuilliEOlsenN. Improvement of medication adherence in adolescents and young adults with SLE using web-based education with and without a social media intervention, a pilot study. Pediatr Rheumatol2018; 16: 18–18.
42.
ThakkarJKurupRLabaTL, et al.Mobile telephone text messaging for medication adherence in chronic disease: A meta-analysis. JAMA Intern Med2016; 176: 340–349.
43.
LeeJAChoiMLeeSAJiangN. Effective behavioral intervention strategies using mobile health applications for chronic disease management: A systematic review. BMC Med Inform Decis Mak18. Epub ahead of print 2018. DOI: 10.1186/s12911-018-0591-0.
44.
SleursKSeysSFBousquetJ, et al.Mobile health tools for the management of chronic respiratory diseases. Allergy Eur J Allergy Clin Immunol2019; 74: 1292–1306.
45.
MillerASCafazzoJASetoE. A game plan: Gamification design principles in mHealth applications for chronic disease management. Health Informatics J2014; 22: 184–193.
46.
DonevantSBEstradaRDCulleyJMHabingBAdamsSA. Exploring app features with outcomes in mHealth studies involving chronic respiratory diseases, diabetes, and hypertension: A targeted exploration of the literature. J Am Med Informatics Assoc2018; 25: 1407–1418.
47.
BlödtSPachDRollSWittCM. Effectiveness of app-based relaxation for patients with chronic low back pain (Relaxback) and chronic neck pain (Relaxneck): Study protocol for two randomized pragmatic trials. Trials2014; 15: 490–490.
48.
KravitzRLSchmidCHMaroisM, et al.Effect of mobile device-supported single-patient multi-crossover trials on treatment of chronic musculoskeletal pain: A randomized clinical trial. JAMA Intern Med2018; 178: 1368–1377.
49.
MorawskiKGhazinouriRKrummeA, et al.Association of a smartphone application with medication adherence and blood pressure control: The MedISAFE-BP randomized clinical trial. JAMA Intern Med2018; 178: 802–809.
50.
BullerDBBerwickMLantzK, et al.Smartphone mobile application delivering personalized, real-time sun protection advice: A randomized clinical trial. JAMA Dermatology2015; 151: 497–504.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
